1. Home
  2. BRBS vs TLSI Comparison

BRBS vs TLSI Comparison

Compare BRBS & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blue Ridge Bankshares Inc.

BRBS

Blue Ridge Bankshares Inc.

HOLD

Current Price

$3.46

Market Cap

322.8M

Sector

Finance

ML Signal

HOLD

Logo TriSalus Life Sciences Inc.

TLSI

TriSalus Life Sciences Inc.

HOLD

Current Price

$4.27

Market Cap

270.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRBS
TLSI
Founded
1893
2010
Country
United States
United States
Employees
N/A
102
Industry
Commercial Banks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
322.8M
270.2M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
BRBS
TLSI
Price
$3.46
$4.27
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
363.4K
387.1K
Earning Date
04-23-2026
05-12-2026
Dividend Yield
24.78%
N/A
EPS Growth
135.48
N/A
EPS
0.01
N/A
Revenue
$111,284,000.00
N/A
Revenue This Year
N/A
$35.45
Revenue Next Year
N/A
$37.58
P/E Ratio
$339.00
N/A
Revenue Growth
123.99
N/A
52 Week Low
$3.23
$2.20
52 Week High
$4.79
$7.95

Technical Indicators

Market Signals
Indicator
BRBS
TLSI
Relative Strength Index (RSI) 50.60 53.11
Support Level $3.41 $3.69
Resistance Level $3.53 $4.39
Average True Range (ATR) 0.07 0.29
MACD -0.01 -0.01
Stochastic Oscillator 56.25 81.08

Price Performance

Historical Comparison
BRBS
TLSI

About BRBS Blue Ridge Bankshares Inc.

Blue Ridge Bankshares Inc is a United States-based company engaged in offering commercial and consumer banking and financial services through its wholly-owned bank subsidiary and its non-bank financial services affiliates. The bank offers services such as checking accounts, savings accounts, money market accounts, cash management accounts, commercial and industrial loans, residential mortgages, commercial mortgages, home equity loans, consumer installment loans, investment accounts, insurance, and others. It generates the majority of its revenue from commercial banking.

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9) agonist, for patients with solid tumors. The company developed Pressure-Enabled Drug Delivery (PEDD) to overcome high intratumoral pressure and off-target delivery. Its 510(k) cleared device, the TriNav Infusion System using PEDD technology, is used for interventional radiology procedures including transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or liver metastases. It has one reportable segment and generates revenue from sales of PEDD infusion systems, principally related to TriNav.

Share on Social Networks: